[DPHARMA] QoQ Annualized Quarter Result on 30-Jun-2020 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
13-Aug-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
30-Jun-2020 [#2]
Profit Trend
QoQ- 4.31%
YoY- -0.32%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 665,816 569,902 581,088 604,088 634,852 576,462 584,942 9.00%
PBT 92,704 76,157 74,248 74,236 70,908 70,809 75,826 14.32%
Tax -22,248 -17,547 -17,692 -17,656 -16,664 -15,536 -18,173 14.42%
NP 70,456 58,610 56,556 56,580 54,244 55,273 57,653 14.29%
-
NP to SH 70,456 58,610 56,556 56,580 54,244 55,273 57,653 14.29%
-
Tax Rate 24.00% 23.04% 23.83% 23.78% 23.50% 21.94% 23.97% -
Total Cost 595,360 511,292 524,532 547,508 580,608 521,189 527,289 8.42%
-
Net Worth 635,424 642,484 584,565 581,725 540,662 525,364 505,919 16.39%
Dividend
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Div - 45,891 4,639 6,843 - 40,937 8,994 -
Div Payout % - 78.30% 8.20% 12.10% - 74.06% 15.60% -
Equity
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Net Worth 635,424 642,484 584,565 581,725 540,662 525,364 505,919 16.39%
NOSH 706,026 706,026 706,026 684,383 684,383 684,383 680,106 2.52%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin 10.58% 10.28% 9.73% 9.37% 8.54% 9.59% 9.86% -
ROE 11.09% 9.12% 9.67% 9.73% 10.03% 10.52% 11.40% -
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 94.30 80.72 83.50 88.27 92.76 84.49 86.71 5.74%
EPS 9.96 8.46 8.21 8.26 7.92 8.25 8.65 9.84%
DPS 0.00 6.50 0.67 1.00 0.00 6.00 1.33 -
NAPS 0.90 0.91 0.84 0.85 0.79 0.77 0.75 12.91%
Adjusted Per Share Value based on latest NOSH - 684,383
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 69.22 59.24 60.41 62.80 66.00 59.93 60.81 9.01%
EPS 7.32 6.09 5.88 5.88 5.64 5.75 5.99 14.28%
DPS 0.00 4.77 0.48 0.71 0.00 4.26 0.93 -
NAPS 0.6606 0.6679 0.6077 0.6047 0.5621 0.5461 0.5259 16.40%
Price Multiplier on Financial Quarter End Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 -
Price 2.75 3.38 3.16 1.62 1.39 1.42 1.40 -
P/RPS 2.92 4.19 3.78 1.84 1.50 1.68 1.61 48.66%
P/EPS 27.56 40.72 38.88 19.60 17.54 17.53 16.38 41.41%
EY 3.63 2.46 2.57 5.10 5.70 5.70 6.10 -29.22%
DY 0.00 1.92 0.21 0.62 0.00 4.23 0.95 -
P/NAPS 3.06 3.71 3.76 1.91 1.76 1.84 1.87 38.82%
Price Multiplier on Announcement Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 03/05/21 22/02/21 12/11/20 13/08/20 18/05/20 13/02/20 29/11/19 -
Price 2.93 3.42 4.04 3.15 1.72 1.64 1.39 -
P/RPS 3.11 4.24 4.84 3.57 1.85 1.94 1.60 55.68%
P/EPS 29.36 41.20 49.71 38.10 21.70 20.24 16.26 48.22%
EY 3.41 2.43 2.01 2.62 4.61 4.94 6.15 -32.48%
DY 0.00 1.90 0.17 0.32 0.00 3.66 0.96 -
P/NAPS 3.26 3.76 4.81 3.71 2.18 2.13 1.85 45.84%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment